660 results on '"Pessina, Ac"'
Search Results
2. Effects of caffeine on glucose tolerance: A placebo-controlled study
3. Immunoreactive endogenous ouabain primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels
4. Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism
5. ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study
6. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma
7. Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study
8. Response to Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism
9. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey
10. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives
11. The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design
12. Ipertensione e surrene
13. Subtle hyperparathyroidism: a novel feature of primary aldosteronism that is corrected by adrenalectomy
14. Under-expression of the Twik-related acid-sensitive K+ 2 channel (Task-2) in aldosterone producing adenoma: genetic and epigenetic mechanisms
15. Antibodies to malondialdehyde oxidized LDL predict cardiovascular events during long-term follow-up in high risk coronary artery disease patients
16. Prorenin receptor activation results in ERK ½ phosphoryalation in human adrenocortical carcinoma cell lines
17. Prorenin Receptor Activation Results In ERK 1/2 Phosphorylation in Human Adrenocortical Carcinoma Cell Line
18. PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?
19. The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma
20. Under-expression of the Twik-related acid-sensitive K+ channel 2 (Task-2) gene in aldosterone-producing adenoma
21. High Expression of The Pro-Renin Receptor in Aldosterone Producing Adenoma Causing Human Primary Aldosteronism
22. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications
23. Cardiovascular Events During Long-Term Follow-Up after Specific Treatment of Primary Aldosteronism
24. Espressione di ‘Ether-à-go go like (Elk)-1 negli adenomi producenti aldosterone (APA)
25. High angiotensin II state without cardiac remodeling (Bartter’s and Gitelman’s syndromes). Are angiotensin II type 2 receptors involved?
26. Long-term changes of left ventricular (LV) structure and function after adrenalectomy or medical treatment for primary aldosteronism
27. Delay in the diagnosis of Conn's syndrome: A single-center experience over 30 years - Response
28. More fuel to the debate on the 'Epidemics of Primary Aldosteronism'
29. Body Mass Index predicts plasma aldosterone concentrations in primary hypertension: Implications for the identification of primary aldosteronism RID E-9967-2010
30. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients
31. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients RID E-9967-2010
32. Renal tubulointerstitial, vascular and glomerular fibrosis are differently regulated by renin angiotensin and endothelin-1 systems in a model of angii-dependent hypertension
33. Prognostic effect of plasma adiponectin (ADPN) in non diabetic high-risk patients
34. Whole transcriptome analysis of aldosterone-producing adenomas reveals the genes underlying responsiveness to ACTH
35. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma
36. Renal damage in primary aldosteronism: results of the PAPY Study
37. Renal damage in primary aldosteronism: results of the PAPY Study
38. Low plasma adiponectin is a hallmark of the metabolic syndrome in non diabetic hypertensive high-risk patients
39. PREDICTORS OF CONGESTIVE HEART FAILURE MORTALITY IN ELDERLY PEOPLE FROM THE GENERAL POPULATION-THE CARDIOVASCULAR STUDY IN THE ELDERLY (CASTEL)
40. Prognostic effect of plasma adiponectin in the high-risk non diabetic coronary artery disease patients (pts) of the 'GENICA' (genetic and environmental factors in coronary atherosclerosis) study
41. The functional and prognostic role of the (CT)-T-242 P22phox Nad(p)h oxidase gene variant in white patients of the 'Genica' study
42. Adiponectin plasma levels in non diabetic, hypertensive and normotensive with and without the metabolic syndrome
43. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension
44. IGG antibodies to malondialdehyde-lysine low-density lipoproteins predict mortality in high risk coronary artery disease patients
45. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension RID E-9967-2010
46. Angiotensin II signaling in the Bartter’s and Gitelman’s syndromes, a negative human model of hypertension
47. Cardiac dysfunction in Bartter's and Gitelman's syndromes
48. Identification of subsets of ACTH-responsive and non-responsive aldosterone-producing-adenoma (APA) by dynamic adrenal vein sampling (AVS)
49. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension RID E-9967-2010
50. The T-786C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high risk patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.